De acordo com a organização, os resumos científicos submetidos para apresentação oral e poster foram mais de 5 mil. Mais de 3 mil foram aceites para serem expostos e apresentados no evento, representando o que de melhor se faz a nível global. Conheça os trabalhos que foram submetidos e aceites no ASH 2017 e que contam com a participação portuguesa.

Comunicações orais

313: "Duration of Deep Molecular Response" Has Most Impact on the Success of Cessation of Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukemia - Results from the EURO-SKI Trial

Session: 632. Chronic Myeloid Leukemia: Therapy: Treatment Discontinuation, Dose Reduction, and Prognostic Indicators

Domingo, 10 de dezembro, 7h30 - Bldg A, Lvl 4, Marcus Aud. 

Coautor: Prof. Doutor António Medina de Almeida, IPO Lisboa

425: Impact of Treatment with Iron Chelation Therapy in Lower-Risk MDS Patients Participating in the European Leukemianet MDS (EUMDS) Registry

Session: 637. Myelodysplastic Syndromes—Clinical Studies: Inflammation, Immunity, and Iron

Domingo, 10 de dezembro, 13h00 -  Bldg B, Lvl 3, B312-B314 

Coautor: Prof. Doutor António Medina de Almeida, Hospital da Luz

911: Myeloablative Conditioning for First Allogeneic Hematopoietic Stem Cell Transplantation in Children with ALL: Total Body Irradiation or Chemotherapy? – a Multicenter EBMT-PDWP Study

Session: 721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Preparative Regimens  

Segunda-feira, 11 de dezembro, 7h15 - Bldg B, Lvl 4, B401-B402 

Coautor: Dr. Manuel Abecasis, IPO Lisboa

Posters

Sábado, 9 de dezembro, 17h30 - 19h30, Bldg A, Lvl 1, Hall A2

1161: Mechanisms of Regulatory T Cell Recruitment By Mesenchymal Stem Cells in Vitro

Session: 506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells: Poster I

Rita I. Azevedo, PhD, Cláudia Lobato da Silva, PhD, Ana Fernandes Platzgummer, PhD, Ekaterina Minskaia, PhD, Ana I.S. Vieira, MSc, Joaquim M.S. Cabral, PhD2 and Joao F. Lacerda, MD, PhD

1004: Epigenetic Control of Foxp3, CAMTA1 and FUT7 Genes in Human Regulatory T Cells

Session: 203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: Poster I

Ekaterina Minskaia, PhD, Barbara C. Saraiva, Maria Soares, PhD1, Ana I.S. Vieira, MSc1 and Joao F Lacerda, MD, PhD

Domingo, 10 de dezembro, 18h00 - 20h00, Bldg A, Lvl 1, Hall A2

3318: Outcomes of Cord Blood Transplantation for Adult Patients with Hodgkin Lymphoma, a Eurocord and EBMT Lymphoma Working Party Study

Session: 732. Clinical Allogeneic Transplantation: Results: Poster II

Coautor: Dr. Manuel Abecasis, IPO Lisboa

3260: Increased Naive, Stem Cell Memory and Terminally Differentiated CD8+ T Cells in Chronic Graft Versus Host Disease

Session: 722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster II

Maria V. Soares, PhD, Rita I. Azevedo, PhD, Inês A. Ferreira, MSc, Bucar Ventura Sara, MSc, Dario Ligeiro, PhD, Ana C Ribeiro, MSc, Paulo N.G. Pereira, Ana C Alho, MD, Eduardo L Espada, MD, Clara Juncal, MD, Nádia Camacho, BSc, Carlos M Martins, MD, José A Carmo, MD, Fernanda Lourenço, MD, Raul Moreno, MD, Carlos Vaz, MD, António Campos, MD, Fernando Campilho, MD, Rosa Ferreira, MD, Jerome Ritz, MD and Joao F Lacerda, MD, PhD

Segunda-feira, 11 de dezembro, 18h00 – 20h00 - Bldg A, Lvl 1, Hall A2 

3865: Prognostic Value of Day 14 Bone Marrow Biopsy (d14BM) in Acute Myeloid Leukemia (AML)

Session: 613. Acute Myeloid Leukemia: Clinical Studies: Poster III

Marcos Lemos, MD, Fatima Costa, MD, Catia L. Gaspar, MD, Margarida Fevereiro, MD, Nuno Almeida, MD, Leonor Sarmento, MD, Luis P Monteiro, MD, Ana Tome, MD and Aida B. Sousa, MD 

3850: Impact of the Type of Anthracycline and of Allogeneic Stem Cell Transplantation in the Treatment of Younger Acute Myeloid Leukemia Patients: Long-Term Follow-up of the EORTC-Gimema AML-10 Trial

Session: 613. Acute Myeloid Leukemia: Clinical Studies: Poster III

Coautor: Prof. Doutor José Eduardo Guimarães